Nucleoside analogue

1 marketed 1 in Phase 3 1 in Phase 2

This page covers all Nucleoside analogue drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Viral DNA polymerase, DNA polymerase, HBV DNA polymerase.

Targets

Viral DNA polymerase · DNA polymerase · HBV DNA polymerase

Marketed (1)

Phase 3 pipeline (1)

Phase 2 pipeline (1)